LUPIN · Concall Summary
LUPIN LIMITED
Lupin Limited reported a record Q1 FY2027 earnings conference call on August 7, 2026, highlighting total revenues exceeding INR 8,000 crores and EBITDA surpassing INR 2,400 crores for the first time. Management noted a 16th consecutive quarter of year-on-year growth, with strong contributions from the U.S. and a 20% plus organic revenue growth outside the U.S. The U.S. business is projected to reach USD 1.1 billion to USD 1.2 billion for the year, despite increased competition in key products. The India business grew 13.9% year-on-year, with a focus on increasing the chronic segment's share. Emerging markets saw a 52% growth, particularly in Brazil. Management reiterated a guidance of high single-digit revenue growth and EBITDA margins around 25% for the year, while expressing optimism about future growth and innovation initiatives.
Management emphasized strong performance and growth across multiple segments.
View source filing →Earlier concalls
- 2026-08-07 — Lupin Limited's investor presentation for Q1 FY27 reported strong financial performance, with sales reaching INR 82,172 …
- 2026-08-06 — Lupin Limited's investor presentation for Q1 FY27 reported strong financial performance, with sales reaching INR 82,172 …
- 2026-05-14 — Lupin Limited's Q4 FY2026 earnings conference call highlighted the company's 15th consecutive quarter of year-over-year …
See LUPIN's full Research Pro page — annual report summary, insider trades, promoter pledge trend, options positioning and Ask-RedixFi AI.
Sign up free